Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI7352 in Healthy Volunteers

Trial Identifier: D5680C00004
Start Date:April 2021
Primary Completion Date: December 2021
Study Completion Date: December 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

GB Harrow, GB, HA1 3UJ